VOIANT

Voiant is the industry‑leading AI‑based clinical trial imaging solution provider with unparalleled scientific and clinical domain expertise — providing biopharmaceutical companies the shortest path to the highest quality imaging endpoint data. With experience supporting 150+ respiratory clinical trials, including IPF and related interstitial lung diseases, and 25+ pulmonary therapy approvals, our AI‑powered Voiant Hub manages the end‑to‑end imaging lifecycle with full site support and sponsor transparency, delivering consistent, innovative respiratory endpoints with unrivalled speed and precision. 

https://www.voiantclinical.com/therapeutic-areas/respiratory/